Journal of Pharmacy And Bioallied Sciences

ERRATUM
Year
: 2021  |  Volume : 13  |  Issue : 1  |  Page : 148-

Tamarindus indica fruit: Pharmacognostical standardization, detection of contaminant, and In Vitro antioxidant activity


 

Correspondence Address:




How to cite this article:
. Tamarindus indica fruit: Pharmacognostical standardization, detection of contaminant, and In Vitro antioxidant activity.J Pharm Bioall Sci 2021;13:148-148


How to cite this URL:
. Tamarindus indica fruit: Pharmacognostical standardization, detection of contaminant, and In Vitro antioxidant activity. J Pharm Bioall Sci [serial online] 2021 [cited 2021 Apr 15 ];13:148-148
Available from: https://www.jpbsonline.org/text.asp?2021/13/1/148/309531


Full Text



In the article titled “Tamarindus indica Fruit: Pharmacognostical Standardization, Detection of Contaminant, and In Vitro Antioxidant Activity”, published on pages 355–363, Issue 4, Volume 11 of Journal of Pharmacy and Bioallied Sciences,[1] the list of authors and affiliations is incorrectly written as

Mohd Amir1, Niyaz Ahmad2, Md Sarfaroz3, Wasim Ahmad4, Sayeed Ahmad5, Mohd Mujeeb5, Faheem Hyder Pottoo4

1Department of Natural Product & Alternative Medicines, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, 1982, Saudi Arabia, 2Department of Pharmaceutics, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, 1982, Saudi Arabia, 3Department of Pharmaceutical Chemistry, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, 1982, Saudi Arabia, 4Department of Pharmacology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 1982, Saudi Arabia, 5Department of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Jamia Hamdard, New Delhi-62, India

The correct list of authors and their affiliations should read as

Mohd Amir1, Niyaz Ahmad2, Md Sarfaroz3, Wasim Ahmad4, Sayeed Ahmad5, Mohd Mujeeb5, Faheem Hyder Pottoo6

1Department of Natural Product & Alternative Medicines, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 1982, Saudi Arabia, 2Department of Pharmaceutics, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 1982, Saudi Arabia, 3Department of Pharmaceutical Chemistry, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 1982, Saudi Arabia, 4Department of Pharmacy, Mohammed Al-Mana College for Medical Sciences, Dammm 34222, Saudi Arabia, 5Department of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Jamia Hamdard, New Delhi-62, India, 6Department of Pharmacology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 1982, Saudi Arabia

References

1Srinivasan R, Gupta P, Rekhi B, Deb P, Nijhawan VS, Prasoon D, et al. Indian academy of cytologists national guidelines for cytopathology laboratories for handling suspected and positive COVID-19 (SARS-cov-2) patient samples. J Cytol 2020;37:67–71.